Advertisement
Advertisement

BNTC

BNTC logo

Benitec Biopharma Inc. Common Stock

11.65
USD
Sponsored
-0.19
-1.60%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

11.67

+0.02
+0.17%

Benitec Biopharma Inc. Common Stock Profile

About

Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.

Info & Links

CEO

Jerel Banks

Headquarters

3940 Trust Way
Hayward, CA 94545, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.benitec.com

Auditor

Baker Tilly US, LLP

Share holders

1,128

Employees

19

Benitec Biopharma Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

400.92M

Enterprise Value

213.00M

Enterprise Value/EBITDA(ttm)

-4.41

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-38.92%

Return on Invested Capital(ttm)

-39.63%

Return on Assets(ttm)

-37.68%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-48.30M

Net Income Available to Common(ttm)

-44.11M

Diluted EPS(ttm)

-1.14

Share Statistics

Beta (5Y Monthly)

0.13

52-Week Change

-11.61%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

34.35M

Dividend Yield

0.00%

Float4

32.70M

% Held by Insiders

4.80%

% Held by Institutions

52.19%

Balance Sheet

Total Cash(mrq)

188.90M

Total Cash Per Share(mrq)

5.50

Total Debt(mrq)

987.00K

Total Debt/Equity(mrq)

0.53%

Current Ratio(mrq)

67.69%

Quick Ratio(mrq)

67.69%

Book Value Per Share(mrq)

5.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.15

Free Cash Flow(ytd)

-7.14M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement